High Tide Announces Purchases of Shares by Insiders

High Tide (Nasdaq/TSXV: HITI) reported that officers, directors and consultants, led by the CEO, bought 90,882 common shares on the open market between May 6–8, 2026 at an average price of $3.39.

Rhea-AI Summary

High Tide (Nasdaq/TSXV: HITI) reported that officers, directors and consultants, led by the CEO, bought 90,882 common shares on the open market between May 6–8, 2026 at an average price of $3.39. Following these purchases, insiders and certain consultants hold 7,720,360 shares, about 8.8% of outstanding shares. The company also highlighted a $40 million credit facility term sheet with a Big 5 Canadian bank, record quarterly medical cannabis distribution volumes at Remexian, and German market share for Remexian of over 14%.

Positive

• Insiders bought 90,882 shares between May 6–8, 2026
• Average insider purchase price was $3.39 per HITI share
• Insiders and consultants now hold 7.72M shares, 8.8% ownership
• $40 million credit facility term sheet with Big 5 Canadian bank
• Record quarterly medical cannabis distribution volumes at Remexian
• Remexian Germany market share now exceeds 14%, more than doubled

Negative

• Credit facility is at term sheet stage, not yet finalized
• Forward-looking expectations are subject to numerous stated risk factors

Argus May 11 session

-1.20% close to close Open Argus

Details

News Market Reaction – HITI

In the May 11 session, HITI declined 1.20%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights insider alignment, with 90,882 shares bought at an average of $3.39, br...

Analysis

This announcement highlights insider alignment, with 90,882 shares bought at an average of $3.39, bringing insider and consultant holdings to 7,720,360 shares, or 8.8% of the company. It comes after a $40 million credit facility term sheet and BfArM data showing Remexian’s German market share above 14%. Investors may watch upcoming financial results, progress on closing the credit facilities, and trends in Canadian and German cannabis volumes to assess execution.

Key Figures

Insider share purchases: 90,882 shares Average purchase price: $3.39 per share Insider ownership: 7,720,360 shares +5 more

Insider share purchases

90,882 shares

Aggregate insider and consultant open-market buys May 6–8, 2026

Average purchase price

$3.39 per share

Average price paid by insiders for common shares

Insider ownership

7,720,360 shares

Total common shares owned or controlled by insiders and certain consultants

Ownership percentage

8.8%

Portion of issued and outstanding common shares held by insiders and consultants

Credit facility size

$40 million

New senior lending relationship term sheet with a Big 5 Canadian bank

German market share

Over 14%

Remexian medical cannabis market share in Germany per BfArM Q1 2026 data

Canna Cabana locations

221 locations

Canadian Canna Cabana retail stores operated by High Tide

Canadian market share

12%

Share of Canadian cannabis market held by bricks-and-mortar operations

Historical Context

5 past events · Latest: May 05

5 events

1. May 05

   Credit facilities term sheet

   24h Move

   -2.1%

   Announced $40M senior secured credit facilities with a Big 5 Canadian bank.

2. Apr 23

   Trading investigation

   24h Move

   -7.0%

   Proactive investigation into unusual trading patterns in common shares.

3. Apr 20

   Store opening

   24h Move

   +1.6%

   Opened new Canna Cabana store in Caledonia, expanding Canadian footprint.

4. Apr 13

   Conference appearances

   24h Move

   +0.0%

   Planned executive presentations at multiple cannabis and investor conferences.

5. Apr 01

   CBD pilot opportunity

   24h Move

   -0.9%

   NuLeaf Naturals to pursue participation in a U.S. Medicare CBD pilot program.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

credit facility, term sheet, medical cannabis, BfArM, +2 more

6 terms

credit facility financial

"We secured a new senior lending relationship with a Big 5 Canadian bank through a $40 million credit facility term sheet"

A credit facility is a flexible loan arrangement that allows a borrower to access funds up to a set limit whenever needed, similar to a company having an overdraft option on a bank account. It matters to investors because it indicates how easily a business can secure cash when required, affecting its ability to manage expenses, invest, or respond to financial challenges.

term sheet financial

"through a $40 million credit facility term sheet, reported record quarterly medical cannabis distribution volumes"

A term sheet is a short, non-binding summary of the main points agreed between parties before a formal investment, loan, or acquisition is completed. Think of it as a blueprint that lists price, ownership split, key rights and conditions, and timelines so everyone knows the deal’s structure before lawyers draft final contracts. Investors care because it signals the likely economic terms, risks, and protections they will get and can make or break whether a transaction proceeds.

medical cannabis medical

"Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products"

Medical cannabis is the use of cannabis plant extracts or compounds such as THC and CBD as prescribed or recommended to treat symptoms or medical conditions. Think of it as a plant-based medicine that can relieve pain, nausea, muscle spasms or other symptoms where conventional drugs may not work; for investors it matters because legal status, clinical evidence, supply rules and insurance coverage determine market size, licensing value and revenue potential.

BfArM regulatory

"newly released BfArM Q1 2026 data indicates that Remexian's market share in Germany has risen"

Germany’s Federal Institute for Drugs and Medical Devices (BfArM) is the national regulator that evaluates, approves and monitors medicines, medical devices and related safety information. For investors, BfArM rulings act like traffic signals for healthcare companies: clearances speed products to market and revenue, while rejections, restrictions or safety warnings can delay launches, reduce sales and change a company’s risk profile and valuation.

TSXV financial

"recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025"

TSXV (TSX Venture Exchange) is a public stock exchange that lists smaller, early-stage companies, often in natural resources, technology, and other growth sectors. Think of it as a marketplace for startups where investors can find higher-risk, higher-upside opportunities; listing there signals lighter regulatory requirements and thinner trading volume than major exchanges, so price swings and the ability to buy or sell shares can be larger factors for investors to consider.

forward-looking statements regulatory

"CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain "forward-looking information" and "forward-looking statements"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CALGARY, AB, May 11, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, today announced that certain officers, directors, and consultants, led by the Company's President and Chief Executive Officer (together, the "Insiders"), in the aggregate, acquired 90,882 common shares in the capital of High Tide ("Common Shares") on the open market between May 6, 2026, and May 8, 2026, at an average price of $3.39 per Common Share. The purchase of Common Shares by the Insiders reflects confidence in the intrinsic value of the stock and the near-term and long-term growth prospects of the Company. With these purchases, insiders and certain consultants, in the aggregate, now own or control 7,720,360 Common Shares, representing approximately 8.8% of the Company's issued and outstanding Common Shares as of today.

"Over the last week, High Tide has continued to demonstrate why we believe we are one of the strongest operators in the global cannabis industry. We secured a new senior lending relationship with a Big 5 Canadian bank through a $40 million credit facility term sheet, reported record quarterly medical cannabis distribution volumes at Remexian, and completed a highly productive institutional investor roadshow across three cities. In addition, newly released BfArM Q1 2026 data indicates that Remexian's market share in Germany has risen to over 14%, more than doubling its share since our transaction, and further validating the strength of our international strategy," said Raj Grover, Founder and Chief Executive Officer of High Tide.

"I am very pleased to have increased my own ownership position alongside several members of our Board and leadership team following these developments. We believe the operational momentum across our retail platform, international business, and balance sheet continues to strengthen, and these insider purchases reflect our confidence in the long-term value we are building," added Mr. Grover.

ABOUT HIGH TIDE

High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:

Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 221 domestic locations and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.

Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.

High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

CONTACT INFORMATION

Media Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee@hightideinc.com
403-770-3080

Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the Company's near‑term and long‑term growth prospects and the expected benefits of its operational and international strategy; the anticipated effect of the recent insider purchases and the Company's expectations regarding future value creation; the expected completion, timing and terms of any credit facility or lending arrangement referenced in this news release (including any term sheet), and the expected benefits thereof; and management's expectations regarding the Company's operational momentum and future performance. Forward‑looking statements are based on management's current expectations and assumptions as of the date of this news release, including assumptions regarding: the Company's ability to negotiate and execute definitive documentation for any financing or credit facility on acceptable terms and satisfy any conditions precedent; the accuracy and continued applicability of third‑party and internal market data referenced in this news release; the Company's ability to execute its business plans; and general economic, market and regulatory conditions. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-announces-purchases-of-shares-by-insiders-302767850.html

SOURCE High Tide Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider share purchases did High Tide (HITI) announce on May 11, 2026?

High Tide reported that insiders and certain consultants bought 90,882 HITI common shares. According to High Tide, these open-market purchases occurred between May 6–8, 2026 at an average price of $3.39 per share and increased total insider-related holdings to 7,720,360 shares.

How much of High Tide (HITI) is now owned by insiders after the May 2026 purchases?

After the May 2026 insider buying, insiders and certain consultants collectively hold about 8.8% of High Tide shares. According to High Tide, this represents ownership or control of 7,720,360 common shares out of the company’s issued and outstanding share count as of the announcement date.

What is the $40 million credit facility term sheet High Tide (HITI) mentioned?

High Tide announced a $40 million credit facility term sheet with a Big 5 Canadian bank. According to High Tide, this senior lending relationship remains subject to negotiating and executing definitive documentation and satisfying conditions precedent, so the credit facility is not yet completed or guaranteed.

What recent performance did Remexian contribute to High Tide (HITI) in Q1 2026?

Remexian delivered record quarterly medical cannabis distribution volumes for High Tide. According to High Tide, newly released BfArM Q1 2026 data show Remexian’s German market share has risen to over 14%, more than doubling since High Tide’s transaction, supporting its international medical cannabis distribution strategy.

How large is High Tide’s Canna Cabana retail footprint and market share in Canada?

High Tide reports that Canna Cabana is Canada’s largest cannabis retail chain by store count. According to High Tide, it operates 221 domestic locations plus one international site and holds a growing 12% share of the Canadian cannabis retail market across several provinces.

What risks and uncertainties does High Tide (HITI) highlight with its forward-looking statements?

High Tide notes that its forward-looking statements involve significant risks and uncertainties. According to High Tide, actual results may differ materially due to factors beyond its control, including financing execution, market conditions and regulatory changes, as outlined in its annual information form and other public filings.